Oncogenic Mutations of PIK3CA in Human Cancers

Yardena Samuels, T Waldman

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

The involvement of the PIK3CA gene product p110 alpha, the catalytic subunit of phosphatidylinositol 3-kinase (PI3K), in human cancer has been suggested for over 15 years, and support for this proposal had been provided by both genetic and functional studies, including most recently the discovery of common activating missense mutations of PIK3CA in a wide variety of common human tumor types. This chapter will focus on the discovery of these mutations and describes their relevance to a wide range of common human tumor types. Of note, the identification and functional analysis of the PIK3CA gene are reviewed in other chapters in this book. However, a brief mention will be made here of its general properties as background to our focus on the discovery of its cancer-specific mutations.
Original languageEnglish
Title of host publicationPHOSPHOINOSITIDE 3-KINASE IN HEALTH AND DISEASE, VOL 2
Pages21-41
Number of pages21
DOIs
StatePublished - 2011

Publication series

NameCurrent Topics in Microbiology and Immunology

Fingerprint

Dive into the research topics of 'Oncogenic Mutations of PIK3CA in Human Cancers'. Together they form a unique fingerprint.

Cite this